Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Biosynthesis of Lipids01:29

Biosynthesis of Lipids

1
Microbial membranes exhibit remarkable diversity in lipid composition, reflecting evolutionary adaptations to various environmental conditions. The three domains of life—Bacteria, Archaea, and Eukarya—synthesize membrane lipids through distinct biosynthetic pathways, leading to fundamental structural differences that impact membrane stability, function, and adaptability.Fatty Acid-Based Lipids in Bacteria and EukaryaBacteria and eukaryotes share a common fatty acid biosynthesis...
1
Peptidoglycan Synthesis01:28

Peptidoglycan Synthesis

1
Structure of PeptidoglycanPeptidoglycan is a vital structural component of the bacterial cell wall, providing mechanical strength and shape to the cell. It consists of repeating units of two sugars—N-acetylglucosamine (NAG) and N-acetylmuramic acid (NAM)—linked by β-1,4 glycosidic bonds. These sugar chains are cross-linked by short peptide chains, forming a mesh-like polymer that surrounds the bacterial plasma membrane.Cytoplasmic Phase – Precursor SynthesisPeptidoglycan...
1
Adrenergic Agonists: Chemistry and Structure-Activity Relationship01:16

Adrenergic Agonists: Chemistry and Structure-Activity Relationship

2.6K
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
2.6K
Prodrugs01:30

Prodrugs

2.5K
Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
2.5K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

554
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
554
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents01:20

Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents

349
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
349

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficient bicycle-sharing rebalancing via demand distribution-based integer programming model and neural lagrangian acceleration.

Scientific reports·2026
Same author

Evaluation of [18F]MFPBG: a novel automatically radiolabeled probe for NET PET imaging.

EJNMMI research·2026
Same author

Economic development and under-five mortality: a global longitudinal analysis of lagged effects and between-country inequalities.

BMC public health·2026
Same author

Population pharmacokinetic-pharmacodynamic analysis and dose optimisation of ciprofol in paediatric anaesthesia.

British journal of anaesthesia·2026
Same author

Conjugated Polymer Semiconductors Enabled Multifunctional Interfacial Engineering for High-Performance Inverted Perovskite Solar Cells.

Advanced materials (Deerfield Beach, Fla.)·2026
Same author

Risk Factors Analysis and Prediction Model for Malignant Cerebral Edema Following Mechanical Thrombectomy in Patients With Large Vessel Occlusive Stroke.

Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·2026

Related Experiment Video

Updated: Jun 5, 2025

Split-and-pool Synthesis and Characterization of Peptide Tertiary Amide Library
13:37

Split-and-pool Synthesis and Characterization of Peptide Tertiary Amide Library

Published on: June 20, 2014

18.1K

Peptaibols: Diversity, bioactivity, and biosynthesis.

Xuewen Hou1, Ruonan Sun1, Yanyan Feng1

  • 1Key Laboratory of Marine Drugs, Chinese Ministry of Education, School of Medicine and Pharmacy, Ocean University of China, Qingdao 266003, China.

Engineering Microbiology
|December 4, 2024
PubMed
Summary

Peptaibols, fungal peptides with unique amino acids, show diverse bioactivities like antimicrobial and cytotoxic effects. This review highlights their biosynthesis and potential as pharmaceuticals.

Keywords:
Bioactivity, anti-infectionBiosynthesisPeptaibolsStructural diversity

More Related Videos

A Customizable Approach for the Enzymatic Production and Purification of Diterpenoid Natural Products
07:59

A Customizable Approach for the Enzymatic Production and Purification of Diterpenoid Natural Products

Published on: October 4, 2019

9.7K
Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B
11:44

Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B

Published on: January 19, 2022

2.4K

Related Experiment Videos

Last Updated: Jun 5, 2025

Split-and-pool Synthesis and Characterization of Peptide Tertiary Amide Library
13:37

Split-and-pool Synthesis and Characterization of Peptide Tertiary Amide Library

Published on: June 20, 2014

18.1K
A Customizable Approach for the Enzymatic Production and Purification of Diterpenoid Natural Products
07:59

A Customizable Approach for the Enzymatic Production and Purification of Diterpenoid Natural Products

Published on: October 4, 2019

9.7K
Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B
11:44

Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B

Published on: January 19, 2022

2.4K

Area of Science:

  • Biochemistry
  • Pharmacology
  • Mycology

Background:

  • Peptaibols are amphipathic polypeptides (5-20 residues) from fungal nonribosomal peptide synthetase (NRPS) pathways.
  • They contain non-proteinogenic amino acids (e.g., α-aminoisobutyrate, isovaline), contributing to their bioactivities.
  • Five peptaibols are commercially available as biocontrol agents, increasing scientific interest.

Purpose of the Study:

  • To review advancements in peptaibol research.
  • To summarize progress in structural characterization and biosynthesis elucidation.
  • To explore the bioactivities and pharmaceutical potential of peptaibols.

Main Methods:

  • Literature review focusing on structural characterization.
  • Analysis of studies on peptaibol biosynthetic pathways.
  • Compilation of research on peptaibol bioactivities.

Main Results:

  • Peptaibols exhibit significant antimicrobial, cytotoxic, and neuroleptic properties.
  • Understanding of NRPS pathways has advanced peptaibol biosynthesis elucidation.
  • Progress in structural and bioactivity studies supports pharmaceutical development.

Conclusions:

  • Peptaibols represent a promising class of peptides with diverse therapeutic applications.
  • Further research into their biosynthesis and bioactivities can accelerate pharmaceutical development.
  • This review consolidates current knowledge to guide future peptaibol research.